NCT01426568 A Trial of Multi-convergent Therapy for Functional Symptoms and Stress in Patients With Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT01410435 Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease Status COMPLETED Phase PHASE3
NCT01369355 A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) Status COMPLETED Phase PHASE3
NCT01369342 A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2) Status COMPLETED Phase PHASE3
NCT01369329 A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1) Status COMPLETED Phase PHASE3
NCT01352221 Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) Status COMPLETED Phase PHASE3
NCT01341808 Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients Status COMPLETED Phase PHASE4
NCT01340872 Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) Status COMPLETED Phase PHASE3
NCT01296841 Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care Status COMPLETED Phase PHASE2
NCT01293656 Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166) Status WITHDRAWN Phase N/A
NCT01244386 Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease Status UNKNOWN Phase N/A
NCT01237847 A Brief Intervention to Improve Adherence in Teens With Inflammatory Bowel Disease Status UNKNOWN Phase NA
NCT01221818 A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01213680 Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease Status COMPLETED Phase PHASE1
NCT01169207 Johns Hopkins Crohn's Disease and Ulcerative Colitis Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01169194 Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS) Status ACTIVE_NOT_RECRUITING Phase N/A